UIC researchers find promising new targets for a...(elop new drugs that act on the targets i...)
Navigation Links
UIC researchers find promising new targets for antibiotics
Date:8/30/2007
elop new drugs that act on the targets in the course of evolution."
"The ribosome is the perfect target," he said. "More than half of all known antibiotics arrest cell growth by interfering with the ribosomal functions and inhibiting protein synthesis. This is an innovative concept, targeting new sites in the ribosome."
'/>"/>
| Contact: Sam Hostettler samhos@uic.edu 312-355-2522 University of Illinois at Chicago Source:Eurekalert |
Related biology news :
1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. NYU researchers simulate molecular biological clock
5. Researchers reveal the infectious impact of salmon farms on wild salmon
6. Researchers identify target for cancer drugs
7. Vital step in cellular migration described by UCSD medical researchers
8. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 277 percent of European pigs are castrated without anesthetic 2The Unexpected Gifts of Alzheimers 47597 1The Unexpected Gifts of Alzheimers 47597 2The Unexpected Gifts of Alzheimers 47597 3iMedica Participates in American College of Physicians EHR Partners Program 47594 1iMedica Participates in American College of Physicians EHR Partners Program 47594 2iMedica Participates in American College of Physicians EHR Partners Program 47594 3QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 1QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 2QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 3QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 4QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 5QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 6QLT announces positive results from the evaluation of Visudyne 28R 29 combination therapy 47591 7
Other Biology News:Value of services performed by insects tops $57 billion in US 2Value of services performed by insects tops $57 billion in US 3Discovery may speed forest biotechnology 2Discovery may speed forest biotechnology 3
Breaking Biology Technology:Dendreon Appoints Hans Bishop as Chief Operating Officer 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 2Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease 3
[0] Dendreon Appoints Hans Bishop as Chief Operating Officer[0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum[0] Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease
Other Biology Technology:MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008 2SuperGen Reports 2008 Second Quarter Financial Results 2SuperGen Reports 2008 Second Quarter Financial Results 3SuperGen Reports 2008 Second Quarter Financial Results 4SuperGen Reports 2008 Second Quarter Financial Results 5SuperGen Reports 2008 Second Quarter Financial Results 6SuperGen Reports 2008 Second Quarter Financial Results 7SuperGen Reports 2008 Second Quarter Financial Results 8SuperGen Reports 2008 Second Quarter Financial Results 9SuperGen Reports 2008 Second Quarter Financial Results 10SuperGen Reports 2008 Second Quarter Financial Results 11SuperGen Reports 2008 Second Quarter Financial Results 12SuperGen Reports 2008 Second Quarter Financial Results 13
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |